Author |
Message |
WerkstattSend message
Joined: 23 May 09 Posts: 121 Credit: 332,658,194 RAC: 348,006 Level
Scientific publications
|
What happened with the short runs? Did not get one since one week! |
|
|
WerkstattSend message
Joined: 23 May 09 Posts: 121 Credit: 332,658,194 RAC: 348,006 Level
Scientific publications
|
They are back! |
|
|
kain Send message
Joined: 3 Sep 14 Posts: 152 Credit: 826,175,036 RAC: 4,076,927 Level
Scientific publications
|
Short runs (2-3 hours on fastest card) 1
Not really. |
|
|
kain Send message
Joined: 3 Sep 14 Posts: 152 Credit: 826,175,036 RAC: 4,076,927 Level
Scientific publications
|
Still 0... It's quite a long time already. |
|
|
|
I have two with projected time of 30 hours. I estimate the first running now will be close to 48 hours at current rate of crunching. I only have a laptop starter Nividia (I upgraded to a solid state hard drive in December) but normally I do short runs at 10% less than the BOINC estimates.
The first is _2 and the second _4. I will crunch both and see if they are normal recycles or if there are other issues, unless otherwise advised.
Thanks |
|
|
SpeedySend message
Joined: 19 Aug 07 Posts: 43 Credit: 31,091,082 RAC: 4,197 Level
Scientific publications
|
Can anyone let me know what type of science tasks e13s125_e11s27f99-NOELIA_ETQ_bound are contributing to? |
|
|
noeliaSend message
Joined: 5 Jul 12 Posts: 35 Credit: 393,375 RAC: 0 Level
Scientific publications
|
Hi Speedy,
This short tasks are based in the Dopamine 3 receptor. It is a target for treating schizophrenia, Parkinson's, drug abuse and other neurological disorders. This receptor is involved in many complex pathways in the central nervous system and its dysfunction affects in a variety of neuropsychiatric disorders which are not yet well understood.
With this experiments, we are trying to understand how eticlopride (ETQ) interacts with it and exerts its action. This molecule is known to bind and block the receptor, and therefore it is mainly used for the schizophrenia treatment.
It's mechanism of binding, although would be very interesting for the design of other similar molecules, it is yet not known and that's what we are trying to understand with this simulations.
Many thanks for your time!
|
|
|
eXaPowerSend message
Joined: 25 Sep 13 Posts: 293 Credit: 1,897,601,978 RAC: 0 Level
Scientific publications
|
http://www.ebi.ac.uk/pdbe/entry/search/index?text:etq
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753830/
http://www.rcsb.org/pdb/results/results.do?qrid=F3135126&tabtoshow=Current
http://chem.sis.nlm.nih.gov/chemidplus/rn/84226-12-0 |
|
|
SpeedySend message
Joined: 19 Aug 07 Posts: 43 Credit: 31,091,082 RAC: 4,197 Level
Scientific publications
|
Thanks Nicola for your response. Happy to help |
|
|
|
Hi Speedy,
This short tasks are based in the Dopamine 3 receptor. It is a target for treating schizophrenia, Parkinson's, drug abuse and other neurological disorders. This receptor is involved in many complex pathways in the central nervous system and its dysfunction affects in a variety of neuropsychiatric disorders which are not yet well understood.
With this experiments, we are trying to understand how eticlopride (ETQ) interacts with it and exerts its action. This molecule is known to bind and block the receptor, and therefore it is mainly used for the schizophrenia treatment.
It's mechanism of binding, although would be very interesting for the design of other similar molecules, it is yet not known and that's what we are trying to understand with this simulations.
Many thanks for your time!
Thanks so much Noelia for these clear and precise explanations !
Really appreciated :)
____________
[CSF] Thomas H.V. Dupont
Founder of the team CRUNCHERS SANS FRONTIERES 2.0
www.crunchersansfrontieres |
|
|